U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839299) titled 'Bonafide Sleep Supplement for Menopausal Women With Impaired Sleep' on Sept. 15.
Brief Summary: This open-label study evaluated whether a daily dietary sleep supplement could improve sleep and related daytime functioning in menopausal women aged 40 to 65 with impaired sleep. Participants used the supplement for approximately 12 weeks, followed by a four-week period without the supplement to evaluate changes after discontinuation. Sleep, daytime functioning, product experience, safety, and tolerability were assessed throughout the study.
Study Start Date: Jan. 03, 2025
Study Type: INTERVENTIONAL
Condition:
Sleep Disturbances
In...